Cantourage Group Future Growth
Future criteria checks 5/6
Cantourage Group is forecast to grow earnings and revenue by 90.3% and 35.4% per annum respectively. EPS is expected to grow by 1% per annum. Return on equity is forecast to be 15.3% in 3 years.
Key information
90.3%
Earnings growth rate
1.0%
EPS growth rate
| Pharmaceuticals earnings growth | 19.7% |
| Revenue growth rate | 35.4% |
| Future return on equity | 15.3% |
| Analyst coverage | Low |
| Last updated | 09 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 98 | 5 | 3 | N/A | 1 |
| 12/31/2025 | 67 | 1 | 1 | N/A | 1 |
| 12/31/2024 | 41 | -2 | -1 | N/A | 1 |
| 12/31/2023 | 2 | 0 | N/A | N/A | N/A |
| 9/30/2023 | 1 | 0 | N/A | N/A | N/A |
| 6/30/2023 | 1 | 0 | N/A | N/A | N/A |
| 12/31/2022 | 1 | 0 | N/A | N/A | N/A |
| 12/31/2021 | 5 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HIGH's forecast earnings growth (90.3% per year) is above the savings rate (0.8%).
Earnings vs Market: HIGH's earnings (90.3% per year) are forecast to grow faster than the German market (20.2% per year).
High Growth Earnings: HIGH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HIGH's revenue (35.4% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: HIGH's revenue (35.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HIGH's Return on Equity is forecast to be low in 3 years time (15.3%).